CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
a Phase 1 study to assess safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of ARR-002 in advanced or metastatic ovarian...
Phase 1
Houston, Texas, United States and 5 other locations
The goal of this clinical trial is to learn if OPB-201 is safe in recurrent endometrial and platinum resistant ovarian cancer parti...
Phase 1
Houston, Texas, United States and 4 other locations
A research study evaluating a new oncolytic virus, THEO-260, in patients with advanced ovarian cancer. The trial will investigate d...
Phase 1
Houston, Texas, United States
To develop a shared decision-making (SDM) tool to help Spanish-speaking patients make decisions about their maintenance therapy
Houston, Texas, United States
bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and prima...
Phase 3
Houston, Texas, United States and 32 other locations
To learn if adding lurbinectedin to the combination of paclitaxel and bevacizumab can help to control advanced cancer....
Phase 1
Houston, Texas, United States
Ovarian cancer is a lethal disease with an estimated 310,000 new cases and 200,000 deaths experienced worldwide in 2020. The purpos ...
Phase 2
The Woodlands, Texas, United States and 85 other locations
the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...
Phase 2
The Woodlands, Texas, United States and 46 other locations
combination of NMS-03305293 and topotecan in patients with recurrent ovarian cancer, with dose-limiting toxicity (DLT) escalation. ...
Phase 1
Houston, Texas, United States and 4 other locations
efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...
Phase 2
The Woodlands, Texas, United States and 20 other locations
Clinical trials
Research sites
Resources
Legal